Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07600762
PHASE1

A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants

Official title: A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Nacresertib in Healthy Adult Japanese Subjects

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2026-04-21

Completion Date

2026-06-17

Last Updated

2026-07-20

Healthy Volunteers

Yes

Interventions

DRUG

Nacresertib

Oral tablet

DRUG

Placebo for Nacresertib

Oral tablet

Locations (1)

CenExel ACT- Anaheim Clinical Trials /ID# 282482

Anaheim, California, United States